Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06456684Recruiting

AV133 Longitudinal Imaging Study in Patients With Early and Prdromal Parkinson's Disease

Role: collaborator

NCT05326009Unknown

A Direct Comparative Study of Tau Tracer in Patients With Alzheimer's Disease

Role: collaborator

NCT05260151Unknown

Tau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases

Role: collaborator

All 3 trials loaded